Diphenhydramine hydrochloride

CAS No. 147-24-0

Diphenhydramine hydrochloride ( DPH )

Catalog No. M12021 CAS No. 147-24-0

Diphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 31 In Stock
200MG 43 In Stock
500MG 52 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Diphenhydramine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Diphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive.
  • Description
    Diphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations.
  • Synonyms
    DPH
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    H1 receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    147-24-0
  • Formula Weight
    291.82
  • Molecular Formula
    C17H22ClNO
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 58 mg/mL (198.75 mM); Water: 58 mg/mL (198.75 mM); DMSO: 58 mg/mL (198.75 mM)
  • SMILES
    Cl.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Piao H, et al. Vascul Pharmacol. 2007 Apr;46(4):260-70.
molnova catalog
related products
  • Orphenadrine hydroch...

    Orphenadrine is an anticholinergic drug of the ethanolamine antihistamine class with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions, as well as the treatment of some aspects of Parkinson's disease.

  • JNJ-5207852

    JNJ-5207852 is a novel non-imidazole histamine H3 receptor antagonist with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.

  • MK-7288

    A novel histamine H3 receptor inverse agonist for the treatment of sleep apnoea syndrome.